An Efficient Nomogram to Predict Overall Survival of Patients with Pediatric Ewing’s Sarcoma: A Population-Based Study

References

• Ewing J. Classics in oncology. diffuse endothelioma of bone. James Ewing. Proceedings of the New York pathological society, 1921. CA Cancer J Clin. 1972;22(2):95–98. doi:10.3322/canjclin.22.2.95
   PubMedGoogle Scholar
• Ranft A, Seidel C, Hoffmann C, et al. Quality of survivorship in a rare disease: clinicofunctional outcome and physical activity in an Observational Cohort Study of 618 long-term survivors of Ewing sarcoma. J Clin Oncol. 2017;35(15):1704–1712. doi:10.1200/jco.2016.70.6226
   PubMed Web of Science ®Google Scholar
• Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol. 2000;18(17):3108–3114. doi:10.1200/jco.2000.18.17.3108
   PubMed Web of Science ®Google Scholar
• Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data. J Pediatr Hematol Oncol. 2008;30(6):425–430. doi:10.1097/MPH.0b013e31816e22f3
   PubMed Web of Science ®Google Scholar
• Andreou D, Ranft A, Gosheger G, et al. Which factors are associated with local control and survival of patients with localized pelvic Ewing’s sarcoma? A retrospective analysis of data from the euro-EWING99 trial. Clin Orthop Relat Res. 2020;478(2):290–302. doi:10.1097/corr.0000000000000962
   PubMed Web of Science ®Google Scholar
• Duchman KR, Gao Y, Miller BJ. Prognostic factors for survival in patients with Ewing’s sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol. 2015;39(2):189–195. doi:10.1016/j.canep.2014.12.012
   PubMed Web of Science ®Google Scholar
• Leavey PJ, Mascarenhas L, Marina N, et al. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2008;51(3):334–338. doi:10.1002/pbc.21618
   PubMed Web of Science ®Google Scholar
• Orr WS, Denbo JW, Billups CA, et al. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude children’s research hospital experience. Ann Surg Oncol. 2012;19(12):3816–3822. doi:10.1245/s10434-012-2458-4
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wu Z-Y, Lin Z-Q. A nomogram to predict prognosis in Ewing sarcoma of bone. J Bone Oncol. 2019;15:100223. doi:10.1016/j.jbo.2019.100223
   PubMed Web of Science ®Google Scholar
• Shi J, Yang J, Ma X, Wang X. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study. J Orthop Surg Res. 2020;15(1):88. doi:10.1186/s13018-020-01607-8
   PubMed Web of Science ®Google Scholar
• Zhang J, Pan Z, Yang J, Yan X, Li Y, Lyu J. A nomogram for determining the disease-specific survival in Ewing sarcoma: a population study. BMC Cancer. 2019;19(1):667. doi:10.1186/s12885-019-5893-9
   PubMed Web of Science ®Google Scholar
• Wan ZH, Huang ZH, Chen LB. Survival outcome among patients with Ewing’s sarcoma of bones and joints: a population-based cohort study. Sao Paulo Med J. 2018;136(2):116–122. doi:10.1590/1516-3180.2017.0236230917
   PubMed Web of Science ®Google Scholar
• Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2012;30(33):4148–4154. doi:10.1200/jco.2011.41.5703
   PubMed Web of Science ®Google Scholar
• Chandran R, Kuruva SP, Chennamaneni R, Bala S, Konatam ML, Gundeti S. Outcomes of adult Ewing sarcoma treated with multimodality therapy: a single-institute experience. South Asian J Cancer. 2020;9(4):191–194. doi:10.1055/s-0041-1723108
   PubMed Web of Science ®Google Scholar
• Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010;116(13):3189–3194. doi:10.1002/cncr.25144
   PubMed Web of Science ®Google Scholar
• Wagenmakers EJ, Farrell S. AIC model selection using akaike weights. Psychon Bull Rev. 2004;11(1):192–196. doi:10.3758/bf03206482
   PubMed Web of Science ®Google Scholar
• Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975–1999. Cancer. 2008;113(9):2575–2596. doi:10.1002/cncr.23866
   PubMed Web of Science ®Google Scholar
• Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994. Br J Cancer. 2006;94(1):22–29. doi:10.1038/sj.bjc.6602885
   PubMed Web of Science ®Google Scholar
• Anderson ND dBR, Young MD, Fuligni F, et al. Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science. 2018;361(6405). doi:10.1126/science.aam8419
   Web of Science ®Google Scholar
• Grünewald TG, Bernard V, Gilardi-Hebenstreit P, et al. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat Genet. 2015;47(9):1073–1078. doi:10.1038/ng.3363
   PubMed Web of Science ®Google Scholar
• Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Ethnic and racial differences in patients with Ewing sarcoma. Cancer. 2010;116(4):983–988. doi:10.1002/cncr.24865
   PubMed Web of Science ®Google Scholar
• Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. Conditional survival and predictors of late death in patients with Ewing sarcoma. Pediatr Blood Cancer. 2016;63(6):1091–1095. doi:10.1002/pbc.25945
   PubMed Web of Science ®Google Scholar
• Hesla AC, Tsagozis P, Jebsen N, Zaikova O, Bauer H, Brosjö O. Improved prognosis for patients with Ewing sarcoma in the sacrum compared with the innominate bones: the Scandinavian Sarcoma Group Experience. J Bone Joint Surg Am. 2016;98(3):199–210. doi:10.2106/jbjs.o.00362
   PubMed Web of Science ®Google Scholar
• Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. 2010;116(8):1964–1973. doi:10.1002/cncr.24937
   PubMed Web of Science ®Google Scholar
• Miller BJ, Lynch CF, Buckwalter JA. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing’s sarcoma. Clin Orthop Relat Res. 2013;471(11):3398–3404. doi:10.1007/s11999-013-3147-8
   PubMed Web of Science ®Google Scholar
• Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol. 2015;33(27):3036–3046. doi:10.1200/jco.2014.59.5256
   PubMed Web of Science ®Google Scholar
• Brunetto AL, Castillo LA, Petrilli AS, et al. Carboplatin in the treatment of Ewing sarcoma: results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. Pediatr Blood Cancer. 2015;62(10):1747–1753. doi:10.1002/pbc.25562
   PubMed Web of Science ®Google Scholar
• Grünewald TGP, Cidre-Aranaz F, Surdez D, et al. Ewing sarcoma. Nat Rev Dis Primers. 2018;4(1):5. doi:10.1038/s41572-018-0003-x
   PubMed Web of Science ®Google Scholar
• Friedman DN, Chastain K, Chou JF, et al. Morbidity and mortality after treatment of Ewing sarcoma: a single-institution experience. Pediatr Blood Cancer. 2017;64(11):e26562. doi:10.1002/pbc.26562
   Web of Science ®Google Scholar